Being overweight or obese is more than just a number on the scale
Patients with diabetes are generally at higher risk of certain infections due to elevated blood glucose levels impairing immune cell function, but improved glycaemic control achieved with GLP-1 therapy may actually reduce this baseline infection risk
It reflects the compounding pharmacy's formulation preferences and the prescribing provider's clinical judgment
These gastrointestinal issues can be exacerbated by travel-related stressors, changes in diet, or dehydration, potentially leading to more serious conditions like kidney problems
Bleeding from the junction of the duodenum and jejunum is frequently associated with melena, though this is not necessarily a reliable sign
Since 2022, NCSL has tracked 66 bills in 25 states addressing GLP-1s for obesity treatment, with at least six states expanding access and others restricting it